The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.

Self-reported prevalence of allergic rhinitis estimated by the Agency for Healthcare Research and Quality (AHRQ) in 2003 ranged from 10-30% in adults and nearer to 40% in children. In 2021 ...

The approval was based on data from a Phase III clinical trial that included 1,460 children ages 5 to 11 years old with persistent allergic rhinitis symptoms for a year, despite receiving symptom ...

The Asthma and Allergy Foundation of America has released its 2025 Allergy Capitals report, identifying the most challenging ...

Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...

Offspring allergic outcomes—including rhinitis, paroxysmal wheezing ... and diet quality. Compared to children of avocado non-consumers, children of avocado consumers exhibited a significantly ...

Wichita, Kansas, was the allergy capital of the U.S. in 2025. The top Florida city, Jacksonville, came in at No. 20.

ST. JOSEPH, Mo. (News-Press NOW) — Spring is in full bloom which means allergy season is back.

Allergy sufferers should start taking their controller medications like over-the-counter antihistamines now as spring will bring tree pollen with it, doctors say, and people with chronic respiratory ...

A leading hay fever expert says the majority of sufferers don't seek help or know how to treat it properly, but a new trial ...

for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include children ages 5 through 11 years. Odactra is an allergy immunotherapy and is administered ...

Humidifiers, steam and hot showers serve as symptomatic reliefs. Showers remove any pollens and allergens on the body, while ...